Nathaniel Calloway
Board Member
Lifecore Biomedical, Inc. \De\ (LFCR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nathaniel Calloway
Nathaniel Calloway is recorded as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR). Lifecore Biomedical, Inc. \De\ reported in an 8-K filed August 21, 2024 that Nathaniel Calloway resigned as director, effective August 15, 2024. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed July 1, 2024 that Nathaniel Calloway resigned as Series A Board designee. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed January 10, 2023 that Nathaniel Calloway was appointed Class 2 director, effective January 9, 2023. Equibles holds 4 filed executive changes naming Nathaniel Calloway; each is listed under recent activity with its source filing.
“On August 15, 2024, following the Annual Meeting, Nathaniel Calloway resigned from the Board.”
“Nathaniel Calloway, a partner at 22NW, will resign as one of the two Series A Board designees immediately prior to the 2023 Annual Meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-10–present
-
2023-01-10–2024-08-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lifecore Biomedical, Inc. \De\
Other people whose current roles at this company are on record from its filings.
- Paul Josephs CEO, Board Member
- Craig A. Barbarosh Chairman
- Katrina L. Houde Chairman, Board Member
- Brian McLaughlin CFO
- John Morberg CFO
- Ryan D. Lake CFO
- Christopher S. Kiper Board Member
- Humberto Antunes Board Member
- Humberto C. Antunes Board Member
- James G. Hall Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.